Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MYRIAD GENETICS INC Analyst Recommendations

  • Analyst Consensus: MYGN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.100 Buy 20
    30 Days Ago 2.158 Buy 19
    60 Days Ago 2.263 Buy 19
    90 Days Ago 2.412 Buy 17
    120 Days Ago 2.059 Buy 17

  • Analyst Ratings: MYGN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Benchmark — Hold 08/26/2009 30.00
    Canaccord Adams Hold Buy 08/26/2009 —
    William Blair — Outperform 08/03/2009 —
    Soleil — Buy 07/17/2009 35.00
    Piper Jaffray — Overweight 07/01/2009 42.00
    Benchmark — Hold 07/01/2009 25.00
    RBC Capital Mkts Outperform Sector Perform 07/01/2009 —
    Oppenheimer Outperform Perform 07/01/2009 —
    Morgan Joseph Buy Sell 07/01/2009 24.00
    Morgan Joseph — Buy 05/19/2009 42.00
    RBC Capital Mkts — Outperform 04/09/2009 54.00
    Leerink Swann — Outperform 03/24/2009 —
    UBS — Buy 02/04/2009 94.00
    JMP Securities — Mkt Outperform 02/04/2009 103.00
    Stanford Research — Hold 02/04/2009 93.00
    Benchmark Hold Buy 02/03/2009 88.00
    RBC Capital Mkts — Outperform 02/03/2009 95.00
    Citigroup Hold Buy 11/21/2008 72.00
    Benchmark Buy Hold 11/05/2008 —
    Oppenheimer — Outperform 10/08/2008 92.00
    RBC Capital Mkts — Outperform 09/12/2008 75.00
    Canaccord Adams — Sell 08/20/2008 52.50
    JMP Securities — Mkt Outperform 08/20/2008 87.00
    RBC Capital Mkts Sector Perform Outperform 07/30/2008 —
    UBS — Buy 07/25/2008 75.00
    Broadpoint Capital — Buy 06/30/2008 51.00
    RBC Capital Mkts Underperform Sector Perform 06/30/2008 37.00
    Pacific Growth Equities — Neutral 06/11/2008 41.00
    Canaccord Adams — Sell 06/05/2008 41.50
    RBC Capital Mkts — Underperform 05/28/2008 37.00
    Next